Back to results
US 12,479,837 B2Granted
Reversible DPP1 inhibitors and uses thereof
AssigneeInsmed Incorporated
InventorsAdam J. Plaunt, Adrien Cerdan, Paola Ciapetti, Bastien Goegan
Life of this patent
Estimating the term…
Abstract
Provided herein are compounds of Formula (I), or pharmaceutically acceptable salts or deuterated forms thereof, wherein R0, L and R1 are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I) or pharmaceutically acceptable salt or deuterated form thereof, and methods of using a compound of Formula (I) or pharmaceutically acceptable salt or deuterated form thereof, e.g., in the treatment of a disease that is treatable by administration of a DPP1 inhibitor.
Claims41
A compound of formula (I)
- or a pharmaceutically acceptable salt or deuterated form thereof,
- wherein:
- R0 is
- X1 and X2 are independently O, S, NH, N(C1-6 alkyl), or CR12R13, wherein at least one of X1 and X2 are not CR12R13;
- L is aryl, heterocyclyl, heteroaryl, or
- wherein L is independently substituted by 0-4 R10 and wherein ring B is a carbocycle, or a heterocycle;
- R1 is
- R2 is H, F, Cl, Br, OSO2C1-6 alkyl, or C1-6 alkyl;
- R3 is H, F, Cl, Br, CN, C1-6haloalkyl, SO2C1-6 alkyl, CONH2, or SO2NR4R5, wherein R4 and R5 together with the nitrogen atom to which they are attached form a heterocyclyl;
- X is O, S, CHF, or CF2;
- Y is O, S, or CH2;
- Q is CH or N;
- R6 is C1-6 alkyl optionally substituted by 1, 2 or 3 F, or optionally substituted by OH, OC1-6 alkyl, N(C1-6 alkyl)2, N(C1-6 alkyl)(C1-6alkylene-O—C1-6 alkyl), cycloalkyl, or heterocyclyl;
- R7 is H, F, Cl, Br, or C1-6 alkyl;
- each R8 and R12 are independently H, OH, halogen, NH2, COOH, C1-6 alkyl, C1-6 alkyl-OH, C2-6alkenyl, C1-6alkoxy, O-cycloalkyl, cycloalkyl, C1-6alkylene-carbocyclyl, C1-6alkylene-heteroaryl, halogenated C1-6 alkyl, halogenated C1-6alkoxy, heteroaryl, or carbocyclyl;
- each R13 is independently H, F, Cl, Br, I, or C1-C6 alkyl;
- each R10 is independently oxo, halogen, C1-6 alkyl, C1-6alkoxy, S-C1-6 alkyl, C2-6alkenyl, C2-6alkynyl, C3-6cycloalkyl, cyano, hydroxy, NH2, —NH—C1-6 alkyl, N(C1-6 alkyl)2, COOH, COC1-6 alkyl, COOC1-6 alkyl, CON1-6 alkyl, CON(C1-6 alkyl)2, NHCOC1-6 alkyl, or heterocycle;
- wherein each alkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, and heterocycle are independently optionally substituted with 1-3 substituents selected from halogen, cyano, hydroxy, NH2, and COOH;
- W, X4, and Y2 are each independently CH or N, provided that a maximum of one of W, X4, and Y2 can be N;
- D-E is N(H)—C(O), N(C1-6 alkyl)-C(O), CH2CH2, C(O)—O, or CH2—O;
- R11 is H, C1-6 alkyl, alkylene-O-alkyl, or heterocyclyl;
- and
- i and j are each independently 1, 2 or 3, provided that the sum of i+j is 2, 3, or 4.
20 more elements
A compound having the structure:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.